financetom
Business
financetom
/
Business
/
Enbridge Completes Offerings of Notes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enbridge Completes Offerings of Notes
Jun 20, 2025 2:14 PM

04:53 PM EDT, 06/20/2025 (MT Newswires) -- Enbridge ( ENB ) in a filing Friday afternoon said that on June 20, 2025, it completed the offering of US$400 million aggregate principal amount of its 4.600% Senior Notes due 2028, and US$600 million aggregate principal amount of its 4.900% Senior Notes due 2030, and US$900 million aggregate principal amount of its 5.550% Senior Notes due 2035 and an additional US$350 million aggregate principal amount of its 5.950% Senior Notes due 2054.

It added the new 2054 Notes constitute a further issuance of, and form a single series with, the $800 million aggregate principal amount outstanding of the corporation's 5.950% Senior Notes due 2054 issued on April 5, 2024. The Notes are fully and unconditionally guaranteed by Enbridge Energy Partners, L.P. and Spectra Energy Partners, LP, each of which is an indirect, wholly-owned subsidiary of the corporation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ImmunityBio Says Anktiva Now Available Under US Commercial, Government Insurance Plans
ImmunityBio Says Anktiva Now Available Under US Commercial, Government Insurance Plans
Aug 12, 2024
09:25 AM EDT, 08/12/2024 (MT Newswires) -- ImmunityBio ( IBRX ) said Monday that Anktiva is now available for patients under both commercial and government insurance plans in the US. The US Food and Drug Administration approved Anktiva, the company's immunotherapy to treat Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer, in April. Additionally, ImmunityBio ( IBRX ) has started the filing...
Wave Life Sciences' Duchenne MD Treatment Candidate Gets US FDA Rare Pediatric Disease Designation
Wave Life Sciences' Duchenne MD Treatment Candidate Gets US FDA Rare Pediatric Disease Designation
Aug 12, 2024
09:26 AM EDT, 08/12/2024 (MT Newswires) -- Wave Life Sciences ( WVE ) said Monday the US Food and Drug Administration has given rare pediatric disease designation to its drug candidate WVE-N531 to treat boys with Duchenne muscular dystrophy who are amenable to exon 53 skipping. The drug is being assessed in a trial that enrolled 11 boys with the...
EnLink Midstream to Launch Senior Notes Offering
EnLink Midstream to Launch Senior Notes Offering
Aug 12, 2024
09:25 AM EDT, 08/12/2024 (MT Newswires) -- EnLink Midstream ( ENLC ) said Monday that it plans to launch an offering of senior notes. The midstream energy company said it plans to use the net proceeds to repay borrowings under its revolving credit facility, as well as an accounts receivable securitization facility. EnLink said the offering will be fully guaranteed...
What's Going On With Bitcoin Mining Stock Marathon Digital Monday?
What's Going On With Bitcoin Mining Stock Marathon Digital Monday?
Aug 12, 2024
Marathon Digital Holdings Inc ( MARA ) shares are trading lower. The company on Monday announced a proposed private offering of convertible senior notes. What Happened: Bitcoin (CRYPTO: BTC) mining company Marathon Digital ( MARA ) said it intends to offer $250 million worth of convertible senior notes due 2031 in a private offering to institutional buyers. The company expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved